Literature DB >> 1695254

Cloning and characterization of human immunodeficiency virus type 1 variants diminished in the ability to induce syncytium-independent cytolysis.

M Stevenson1, S Haggerty, C Lamonica, A M Mann, C Meier, A Wasiak.   

Abstract

The phenomenon of interference was exploited to isolate low-abundance noncytopathic human immunodeficiency virus type 1 (HIV-1) variants from a primary HIV-1 isolate from an asymptomatic HIV-1-seropositive hemophiliac. Successive rounds of virus infection of a cytolysis-susceptible CD4+ cell line and isolation of surviving cells resulted in selective amplification of an HIV-1 variant reduced in the ability to induce cytolysis. The presence of a PvuII polymorphism facilitated subsequent amplification and cloning of cytopathic and noncytopathic HIV-1 variants from the primary isolate. Cloned virus stocks from cytopathic and noncytopathic variants exhibited similar replication kinetics, infectivity, and syncytium induction in susceptible host cells. The noncytopathic HIV-1 variant was unable, however, to induce single-cell killing in susceptible host cells. Construction of viral hybrids in which regions of cytopathic and noncytopathic variants were exchanged indicated that determinants for the noncytopathic phenotype map to the envelope glycoprotein. Sequence analysis of the envelope coding regions indicated the absence of two highly conserved N-linked glycosylation sites in the noncytopathic HIV-1 variant, which accompanied differences in processing of precursor gp160 envelope glycoprotein. These results demonstrate that determinants for syncytium-independent single-cell killing are located within the envelope glycoprotein and suggest that single-cell killing is profoundly influenced by alterations in envelope sequence which affect posttranslational processing of HIV-1 envelope glycoprotein within the infected cell.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1695254      PMCID: PMC249674     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  The role of mononuclear phagocytes in HTLV-III/LAV infection.

Authors:  S Gartner; P Markovits; D M Markovitz; M H Kaplan; R C Gallo; M Popovic
Journal:  Science       Date:  1986-07-11       Impact factor: 47.728

2.  Genetic variation in AIDS viruses.

Authors:  J M Coffin
Journal:  Cell       Date:  1986-07-04       Impact factor: 41.582

3.  Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity.

Authors:  J Sodroski; W C Goh; C Rosen; K Campbell; W A Haseltine
Journal:  Nature       Date:  1986 Jul 31-Aug 6       Impact factor: 49.962

4.  Biological and molecular characterization of human immunodeficiency virus (HIV-1BR) from the brain of a patient with progressive dementia.

Authors:  R Anand; R Thayer; A Srinivasan; S Nayyar; M Gardner; P Luciw; S Dandekar
Journal:  Virology       Date:  1989-01       Impact factor: 3.616

5.  Perturbation of the lipid bilayer of model membranes by synthetic signal peptides.

Authors:  R Nagaraj; M Joseph; G L Reddy
Journal:  Biochim Biophys Acta       Date:  1987-10-16

Review 6.  Mechanisms of cell killing/cytopathic effects by nonhuman retroviruses.

Authors:  H M Temin
Journal:  Rev Infect Dis       Date:  1988 Mar-Apr

7.  Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS.

Authors:  B H Hahn; G M Shaw; M E Taylor; R R Redfield; P D Markham; S Z Salahuddin; F Wong-Staal; R C Gallo; E S Parks; W P Parks
Journal:  Science       Date:  1986-06-20       Impact factor: 47.728

8.  Biologically diverse molecular variants within a single HIV-1 isolate.

Authors:  A G Fisher; B Ensoli; D Looney; A Rose; R C Gallo; M S Saag; G M Shaw; B H Hahn; F Wong-Staal
Journal:  Nature       Date:  1988-08-04       Impact factor: 49.962

Review 9.  Retroviral etiology of the acquired immune deficiency syndrome (AIDS).

Authors:  D J Volsky; K Sakai; M Stevenson; S Dewhurst
Journal:  AIDS Res       Date:  1986-12

10.  Extensive variation of human immunodeficiency virus type-1 in vivo.

Authors:  M S Saag; B H Hahn; J Gibbons; Y Li; E S Parks; W P Parks; G M Shaw
Journal:  Nature       Date:  1988-08-04       Impact factor: 49.962

View more
  23 in total

1.  Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest.

Authors:  S A Stewart; B Poon; J B Jowett; I S Chen
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

2.  Molecular determinants of acute single-cell lysis by human immunodeficiency virus type 1.

Authors:  J Cao; I W Park; A Cooper; J Sodroski
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

3.  Sequences responsible for the distinctive hemolytic potentials of Friend and Moloney murine leukemia viruses are dispersed but confined to the psi-gag-PR region.

Authors:  J Richardson; A Corbin; F Pozo; S Orsoni; M Sitbon
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

4.  A mutation in reverse transcriptase of bis(heteroaryl)piperazine-resistant human immunodeficiency virus type 1 that confers increased sensitivity to other nonnucleoside inhibitors.

Authors:  T J Dueweke; T Pushkarskaya; S M Poppe; S M Swaney; J Q Zhao; I S Chen; M Stevenson; W G Tarpley
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

5.  Human immunodeficiency virus type 1 glycoprotein precursor retains a CD4-p56lck complex in the endoplasmic reticulum.

Authors:  B Crise; J K Rose
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

6.  (Alkylamino) piperidine bis(heteroaryl)piperizine analogs are potent, broad-spectrum nonnucleoside reverse transcriptase inhibitors of drug-resistant isolates of human immunodeficiency virus type 1 (HIV-1) and select for drug-resistant variants of HIV-1IIIB with reduced replication phenotypes.

Authors:  R A Olmsted; D E Slade; L A Kopta; S M Poppe; T J Poel; S W Newport; K B Rank; C Biles; R A Morge; T J Dueweke; Y Yagi; D L Romero; R C Thomas; S K Sharma; W G Tarpley
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

7.  Dissociation of unintegrated viral DNA accumulation from single-cell lysis induced by human immunodeficiency virus type 1.

Authors:  L Bergeron; J Sodroski
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

8.  Recombinational analysis of a natural noncytopathic human immunodeficiency virus type 1 (HIV-1) isolate: role of the vif gene in HIV-1 infection kinetics and cytopathicity.

Authors:  K Sakai; X Y Ma; I Gordienko; D J Volsky
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

Review 9.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

10.  The long terminal repeat is not a major determinant of the cellular tropism of human immunodeficiency virus type 1.

Authors:  R J Pomerantz; M B Feinberg; R Andino; D Baltimore
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.